Safety, side effects, and who should pause before starting All GLP-1 receptor agonists and the GIP/GLP-1 dual agonist tirzepatide share a well-characterized side-effect profile: nausea, vomiting, diarrhea, constipation, abdominal pain, and headache are common
Semaglutide works by mimicking the hormone glucagon-like peptide 1 (GLP-1), and is currently authorised for the treatment of type 2 diabetes patients with insufficient glycaemic control and long-term weight management
Clinically, it manifests as gradual impairments in memory, cognition, language, and daily functioning, often accompanied by behavioral and emotional alterations (Figure 3)
Meet with our physician to assess your goals, health status, and determine if IGF-1 LR3 therapy is appropriate for your needs
Information for healthcare professionals: Exenatide (marketed as Byetta)8/2008 update
The OGTT is now the preferred diagnostic test for dumping syndrome 1,20,85